Tasha N. Sims
Tasha N. Sims
Regeneron, NYU, University of Alberta, Washington University
Verified email at regeneron.com
Title
Cited by
Cited by
Year
The immunological synapse
SK Bromley, WR Burack, KG Johnson, K Somersalo, TN Sims, C Sumen, ...
Annual review of immunology 19 (1), 375-396, 2001
11382001
The immunological synapse balances T cell receptor signaling and degradation
KH Lee, AR Dinner, C Tu, G Campi, S Raychaudhuri, R Varma, TN Sims, ...
science 302 (5648), 1218-1222, 2003
6312003
Opposing effects of PKCθ and WASp on symmetry breaking and relocation of the immunological synapse
TN Sims, TJ Soos, HS Xenias, B Dubin-Thaler, JM Hofman, JC Waite, ...
Cell 129 (4), 773-785, 2007
3672007
CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney
TJ Soos, TN Sims, L Barisoni, K Lin, DR Littman, ML Dustin, PJ Nelson
Kidney international 70 (3), 591-596, 2006
3032006
WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation
IM Antón, MA de la Fuente, TN Sims, S Freeman, N Ramesh, JH Hartwig, ...
Immunity 16 (2), 193-204, 2002
1972002
The immunological synapse: integrins take the stage
TN Sims, ML Dustin
Immunological reviews 186 (1), 100-117, 2002
1952002
Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes
N Anikeeva, K Somersalo, TN Sims, VK Thomas, ML Dustin, Y Sykulev
Proceedings of the National Academy of Sciences 102 (18), 6437-6442, 2005
1782005
Lateral membrane waves constitute a universal dynamic pattern of motile cells
HG Döbereiner, BJ Dubin-Thaler, JM Hofman, HS Xenias, TN Sims, ...
Physical review letters 97 (3), 038102, 2006
1692006
Cytotoxic T lymphocytes form an antigen-independent ring junction
K Somersalo, N Anikeeva, TN Sims, VK Thomas, RK Strong, T Spies, ...
The Journal of clinical investigation 113 (1), 49-57, 2004
1392004
Disturbed MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma.
N Goes, T Sims, J Urmson, D Vincent, V Ramassar, PF Halloran
The Journal of Immunology 155 (10), 4559-4566, 1995
801995
Tumor-reprogrammed resident T cells resist radiation to control tumors
A Arina, M Beckett, C Fernandez, W Zheng, S Pitroda, SJ Chmura, ...
Nature communications 10 (1), 1-13, 2019
672019
Central role for interferon-γ receptor in the regulation of renal MHC expression
Y Takei, TN Sims, J Urmson, PF Halloran
Journal of the American Society of Nephrology 11 (2), 250-261, 2000
312000
In Vivo Class Ii Transactivator Expression In Mice Is Induced By A Non-interferon-γ Mechanism In Response To Local Injury1, 2
TN Sims, NB Goes, V Ramassar, J Urmson, PF Halloran
Transplantation 64 (12), 1657-1664, 1997
241997
Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator
TN Sims, JF Elliott, V Ramassar, DW Denney Jr, PF Halloran
Immunogenetics 45 (3), 220-222, 1997
211997
MHC expression in organ transplants: lessons from the knock-out mice
PF Halloran, N Goes, J Urmson, V Ramassar, M Hobart, T Sims, SL Lui, ...
Transplantation proceedings 29 (1-2), 1041-1044, 1997
161997
The role of the class II transactivator (CIITA) in MHC class I and II regulation and graft rejection in kidney
TN Sims, M Afrouzian, J Urmson, LF Zhu, PF Halloran
American Journal of Transplantation 1 (3), 211-221, 2001
152001
MHC class II regulation in vivo in the mouse kidney
TN Sims, PF Halloran
Microbes and infection 1 (11), 903-912, 1999
151999
Differential usage of class II transactivator promoters PI and PIV during inflammation and injury in kidney
O Takeuchi, TN Sims, Y Takei, V Ramassar, KS Famulski, PF Halloran
Journal of the American Society of Nephrology 14 (11), 2823-2832, 2003
132003
Potential predictive and prognostic biomarkers identified in baseline plasma samples from the VELOUR trial.
TN Sims, B Gao, M Chiron, P Mancini, E Dochy, I Lowy
Journal of Clinical Oncology 33 (15_suppl), e14536-e14536, 2015
112015
First-in-human study of REGN3767 (R3767), a human LAG-3 monoclonal antibody (mAb),±cemiplimab in patients (pts) with advanced malignancies.
KP Papadopoulos, NJ Lakhani, ML Johnson, H Park, D Wang, TA Yap, ...
Journal of Clinical Oncology 37 (15_suppl), 2508-2508, 2019
102019
The system can't perform the operation now. Try again later.
Articles 1–20